Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 4 | 11,416 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
20 Form 4 filings on record, the earliest from Oct 10, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Peter K. Fung - Director | Grant or award | Stock Options (Right to Buy) | 2,854 | $2.19 | $6K | |
| Wendy J. Betts - Director | Grant or award | Stock Options (Right to Buy) | 2,854 | $2.19 | $6K | |
| James Intrater - Director | Grant or award | Stock Options (Right to Buy) | 2,854 | $2.19 | $6K | |
| Grant or award | Stock Options (Right to Buy) | 2,854 | $2.19 | $6K | ||
| Peter K. Fung - Director | Grant or award | Stock Options (Right to Buy) | 3,205 | $1.95 | $6K | |
| Wendy J. Betts - Director | Grant or award | Stock Options (Right to Buy) | 3,205 | $1.95 | $6K | |
| James Intrater - Director | Grant or award | Stock Options (Right to Buy) | 3,205 | $1.95 | $6K | |
| Grant or award | Stock Options (Right to Buy) | 3,205 | $1.95 | $6K | ||
| Wendy J. Betts - Director | Grant or award | Stock Options (Right to Buy) | 1,559 | $4.01 | $6K | |
| James Intrater - Director | Grant or award | Stock Options (Right to Buy) | 1,559 | $4.01 | $6K | |
| Grant or award | Stock Options (Right to Buy) | 1,559 | $4.01 | $6K | ||
| Peter K. Fung - Director | Grant or award | Stock Options (Right to Buy) | 1,559 | $4.01 | $6K | |
| James Intrater - Director | Grant or award | Stock Options (Right to Buy) | 1,736 | $3.60 | $6K | |
| Peter K. Fung - Director | Grant or award | Stock Options (Right to Buy) | 1,736 | $3.60 | $6K | |
| Wendy J. Betts - Director | Grant or award | Stock Options (Right to Buy) | 1,736 | $3.60 | $6K | |
| Grant or award | Stock Options (Right to Buy) | 1,736 | $3.60 | $6K | ||
| James Intrater - Director | Grant or award | Stock Options (Right to Buy) | 18,686 | $6.60 | $4K | |
| Oded Levy - Director | Grant or award | Stock Options (Right to Buy) | 18,686 | $6.60 | $4K | |
| Grant or award | Stock Options (Right to Buy) | 18,686 | $6.60 | $4K | ||
| Stanley K. Lau - Director | Grant or award | Stock Options (Right to Buy) | 18,686 | $6.60 | $4K |
Cardio Diagnostics Holdings, Inc. (CDIO) had 4 insider filings in the last 90 days, with the most recent on 2026-07-02. The full record for CDIO runs to 20 Form 4 filings, the earliest from 2024-10-10. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of CDIO were filed in the last 90 days.
No insider sales of CDIO were filed in the last 90 days.
This page tracks CDIO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add CDIO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.